Robert M. VanHimbergen - 07 Aug 2026 Form 4 Insider Report for Elanco Animal Health Inc (ELAN)

Reporting relationship: EVP and CFO
Issuer ticker: ELAN
Reported as of: 07 Aug 2026
Net transaction value: +$96,926
SEC form: 4
Accepted by SEC: 10 Aug 2026, 16:14:59 UTC
Prior SEC filing: 28 Jul 2026
Source filing: View source filing
Reporting owner signature: /s/ Amy C. Seidel, as Attorney-in-Fact for Robert M. VanHimbergen

Key filing fact

Robert M. VanHimbergen filed Form 4 for Elanco Animal Health Inc (ELAN) on 10 Aug 2026.

Key facts

This page summarizes Robert M. VanHimbergen's Form 4 filing for Elanco Animal Health Inc (ELAN).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 10 Aug 2026, 16:14.

Change

Previous filing in this sequence was filed on 28 Jul 2026.
Current net transaction value: +$96,926.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001724169 Primary reporting owner

VanHimbergen Robert M

Relationship: EVP and CFO
Address: C/O ELANCO ANIMAL HEALTH INCORPORATED, 450 ELANCO CIRCLE, INDIANAPOLIS
Signature: /s/ Amy C. Seidel, as Attorney-in-Fact for Robert M. VanHimbergen
Signature date: 10 Aug 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ELAN transaction

Common Stock

Purchase

Transaction value: $96,926
Shares: +4,200
Change %: +3.2%
Price: $23.08
Shares after: 137,516
Date: 07 Aug 2026
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ELAN transaction Derivative

Deferred Stock Units

Award

Transaction value
Shares: +9
Change %: +7.1%
Price: $22.12^*
Shares after: 134
Date: 07 Aug 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 9
Exercise price
Footnotes: F2, F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Reflects the weighted average price of 4,200 shares of common stock of Elanco Animal Health Inc. purchased by the reporting person in multiple transactions on August 7, 2026 with purchase prices ranging from $23.01 to $23.09 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.

Footnote F2

Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent.

Footnote F3

Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan.